CompletedPhase 1NCT00460876

Phase I Trial of Periocular Topotecan in Retinoblastoma

Studying Hereditary retinoblastoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital JP Garrahan
Principal Investigator
Guillermo L Chantada, MD
Hospital JP Garrahan
Intervention
Topotecan(drug)
Enrollment
5 enrolled
Eligibility
18 years · All sexes
Timeline
20072008

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00460876 on ClinicalTrials.gov

Other trials for Hereditary retinoblastoma

Additional recruiting or active studies for the same condition.

See all trials for Hereditary retinoblastoma

← Back to all trials